Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Dolby Laboratories (DLB) Cash from Restructuring (2019 - 2020)

Dolby Laboratories' Cash from Restructuring history spans 2 years, with the latest figure at $8.1 million for Q4 2020.

For Q4 2020, Cash from Restructuring rose 1571.81% year-over-year to $8.1 million; the TTM value through Dec 2020 reached $9.3 million, down 72.5%, while the annual FY2020 figure was $1.6 million, 95.07% down from the prior year.
Cash from Restructuring reached $8.1 million in Q4 2020 per DLB's latest filing, up from $199000.0 in the prior quarter.
In the past five years, Cash from Restructuring ranged from a high of $27.5 million in Q2 2019 to a low of $116000.0 in Q1 2020.